HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 32.65
-0.18 (-0.55%)
At close: Jan 22, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 13.04 billion as of January 22, 2026. Its market cap has increased by 146.97% in one year.
Market Cap
13.04B
Enterprise Value
12.29B
Revenue
498.51M
Ranking
n/a
PE Ratio
118.89
Stock Price
32.65
Market Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 13.04B, a decrease of -30.86%. That is a compound annual growth rate of -6.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 13.11B | 40.00% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |